S926 Effects of Immune Modifying Therapies on Antibody Responses Following SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease
Year: 2021
Type: conference-abstract
Authors: Gil Melmed, Gregory J. Botwin, Ziad Younis, Douglas C. Wolf, Michael Chiorean, Erica R. Cohen, Brigid Boland, Ann D. Flynn, David Fudman, Jason Hou, Mark Lazarev, Donald F. Lum, Mark C. Mattar, Ryan McConnell, Arthur Ostrov, Nimisha Parekh, Laura Raffals, Sarah Sheibani, Corey Siegel, John Valentine, Bradley Morganstern, Arash Horizon, Swamy Venuturupalli, Daniel J. Wallace, Sarah Glover, Adam C. Ehrlich, Christina Ha, Gaurav Syal, Rashmi Kumar, Keren L. Appel, Angela Mujukian, Shervin Rabizadeh, Edward J. Feldman, Theodore Stein, Susan Cheng, Joseph Ebinger, Kimia Sobhani, Jonathan Braun, Dermot McGovern
Institutions: Cedars-Sinai Medical Center, F. Widjaja Inflammatory Bowel Disease Institute, Gastro One (United States), Atlanta Gastroenterology Associates, Swedish Medical Center, University of California San Diego, University of Utah, The University of Texas Southwestern Medical Center, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Johns Hopkins University, Oregon Clinic, MedStar Georgetown University Hospital, Sutter Health, University of California, Irvine, Mayo Clinic, University of Southern California, Dartmouth–Hitchcock Medical Center, Stony Brook University Hospital, University of Mississippi Medical Center, Temple University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3208639882